Everolimus with Early Reduction or Elimination of Tacrolimus in 719 De Novo Liver Transplant Recipients-12 Month Efficacy and Safety Results from H2304 Study

被引：0
|
作者：
Fung, J. [1 ]
Nevens, F. [1 ]
De Carlis, L. [1 ]
Metselaar, H. J. [1 ]
Beckebaum, S. [1 ]
Saliba, F. [1 ]
Jonas, S. [1 ]
Sudan, D. [1 ]
Fischer, L. [1 ]
Duvoux, C. [1 ]
Chavin, K. D. [1 ]
Koneru, B. [1 ]
Jiang, H. [2 ]
Hexham, J. M. [2 ]
Junge, G. [2 ]
De Simone, P. [1 ]
机构：
[1] H2304 Study Grp, Cleveland, OH USA
[2] Novartis Pharma AG, Basel, Switzerland
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2012年 / 12卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
5
引用
收藏
页码：28 / 28
页数：1
相关论文
共 50 条
  • [1] Evolution of Renal Function with Early Everolimus-Facilitated Reduction or Elimination of Tacrolimus in 719 De Novo Liver Transplant Recipients: 12 Month Data of the H2304 Study
    De Simone, P.
    Nevens, F.
    De Carlis, L.
    Metselaar, H. J.
    Beckebaum, S.
    Saliba, F.
    Jonas, S.
    Sudan, D.
    Fischer, L.
    Duvoux, C.
    Foltys, D.
    Koneru, B.
    Wang, Y.
    Hexham, J. M.
    Junge, G.
    Fung, J.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 : 238 - 238
  • [2] Efficacy and Safety of Everolimus with Early Reduction or Elimination of Tacrolimus in 719 de Novo Liver Transplant Recipients - Results at 12 Months
    De Simone, P.
    Nevens, F.
    Duvoux, C.
    Koneru, B.
    McCormack, L.
    McCaughan, G.
    Navasa, M.
    Dong, G.
    Hexham, J. M.
    Junge, G.
    Fung, J.
    [J]. TRANSPLANTATION, 2012, 94 (10) : 750 - 750
  • [3] Impact of Early Everolimus-Facilitated Reduction or Elimination of Tacrolimus on the Evolution of Renal Function in 719 De Novo Liver Transplant Recipients: 12 Month Data of the H2304 Study
    Metselaar, H. J.
    Saliba, F.
    Schemmer, P.
    Foltys, D.
    Fabregat, J.
    Ericzon, B. -G.
    Dong, G.
    Hexham, J. M.
    Junge, G.
    De Simone, P.
    [J]. TRANSPLANTATION, 2012, 94 (10) : 44 - 44
  • [4] Renal Function with Everolimus and Reduced Tacrolimus in De Novo Liver Transplant Recipients: 12 Month Results of the H2304 Study
    De Simone, P.
    Nevens, F.
    De Carlis, L.
    Metselaar, H. J.
    Beckebaum, S.
    Saliba, F.
    Jonas, S.
    Sudan, D.
    Fischer, L.
    Foltys, D.
    Koneru, B.
    Wang, Y.
    Hexham, J. M.
    Junge, G.
    Fung, J.
    [J]. LIVER TRANSPLANTATION, 2012, 18 : S85 - S86
  • [5] EVEROLIMUS WITH EARLY REDUCTION OR ELIMINATION OF TACROLIMUS: 12 MONTH RESULTS OF A RANDOMIZED, CONTROLLED STUDY IN 719 DE NOVO LIVER TRANSPLANT RECIPIENTS
    Nevens, F.
    De Carlis, L.
    Metselaar, H.
    Saliba, F.
    Beckebaum, S.
    Jonas, S.
    Sudan, D.
    Fischer, L.
    Fung, J.
    Jiang, H.
    Junge, G.
    De Simone, P.
    [J]. JOURNAL OF HEPATOLOGY, 2012, 56 : S551 - S552
  • [6] Efficacy and safety of everolimus in combination with reduced tacrolimus in de novo liver transplant recipients: 36-month results from the randomized H2304 study
    Saliba, Faouzi
    Kaiser, Gernot M.
    De Carlis, Luciano
    Metselaar, Herold J.
    De Simone, Paolo
    Duvoux, Christophe
    Nevens, Frederik
    Fischer, Lutz
    Fung, John J.
    Dong, Gaohong
    Rauer, Barbara
    Junge, Guido
    [J]. HEPATOLOGY, 2013, 58 (06) : 1383A - 1383A
  • [7] EFFICACY AND SAFETY OF EVEROLIMUS WITH EARLY REDUCTION OR ELIMINATION OF TACROLIMUS IN 719 DE NOVO LIVER TRANSPLANT RECIPIENTS: 12 MONTH RESULTS OF A PHASE III, RANDOMIZED, CONTROLLED STUDY
    Saliba, Faouzi
    De Simone, Paolo
    Nevens, Frederik
    De Carlis, Luciano
    Metselaar, Herold
    Beckebaum, Susanne
    Jonas, Sven
    Sudan, Debra
    Fischer, Lutz
    Fung, John J.
    Jiang, Hai
    Junge, Guido
    [J]. HEPATOLOGY, 2011, 54 : 1430A - 1431A
  • [8] EFFICACY AND SAFETY OF EVEROLIMUS IN COMBINATION WITH REDUCED TACROLIMUS IN DE NOVO LIVER TRANSPLANT RECIPIENTS: 36-MONTH RESULTS FROM THE RANDOMIZED H2304 STUDY
    Saliba, F.
    Duvoux, C.
    Durand, F.
    Neau-Cransac, M.
    Hardwigsen, J.
    Pageaux, G.
    Di Giambattista, F.
    [J]. TRANSPLANT INTERNATIONAL, 2015, 28 : 18 - 18
  • [9] RANDOMIZED, MULTICENTER STUDY OF EVEROLIMUS WITH EARLY REDUCTION OR ELIMINATION OF TACROLIMUS IN 719 DE NOVO LIVER TRANSPLANT RECIPIENTS: RESULTS AT 12 MONTHS
    Saliba, Faouzi
    Duvoux, Christophe
    Durand, Francois
    Neau-Cransac, Martine
    Hardwigsen, Jean
    Pageaux, Georges
    Boleslawski, Emmanuel
    [J]. TRANSPLANT INTERNATIONAL, 2012, 25 : 39 - 39
  • [10] Efficacy and Safety of Everolimus in De Novo Liver Transplant Recipients-12 Month Results of a Randomized, Multicenter Study.
    Fung, J.
    Nevens, F.
    De Carlis, L.
    Metselaar, H. J.
    Beckebaum, S.
    Saliba, F.
    Jonas, S.
    Sudan, D.
    Fischer, L.
    Duvoux, C.
    Chavin, K. D.
    Jiang, H.
    Hexham, J. M.
    Junge, G.
    De Simone, P.
    [J]. LIVER TRANSPLANTATION, 2012, 18 : S109 - S110
12345